Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • All materials must be written in standard english.
  • Manuscript must be double-spaced throughout.
  • Type written using 12 font size Times New Roman on A4 paper MS WORD format.
  • The page number and line number must be assigned throughout the manuscript continuously from the title page.
  • Divide your article (excluding abstract, keywords, acknowledgements, data availability, conflict of interest, authors’ contribution, and references) into clearly defined and numbered sections using Arabic numerals (1, 2, 3, etc.). Subsections should be numbered 1.1 (then 1.1.1, 1.1.2, …), 1.2, etc.
  • One of the manuscript author(s) should be corresponding author, who takes responsibility for the paper during submission and peer review.
  • Superscript numbers should be used to link author with institution and an asterisk to refer to the corresponding author.
  • The abbreviations and acronyms should be defined the first time they used in the manuscript.
  • Do not use abbreviations in the title until and unless they are unavoidable.
  • Use the standard mathematical notation for formulae/symbols.
  • Genus and species names should be in italics.
  • Internationally accepted (SI) signs and symbols should be used for units.
  • The Tables and Figures must not be submitted separately and should appear in the text after the reference section.

Author Guidelines

Instructions to Authors

Asian Journal of Medical and Biological Research is an official journal of Ebu Press Ltd.

Asian Journal of Medical and Biological Research publishes high quality and novelty scientific papers focusing on Medical and Biological Sciences (Medical Science, Dental Science, Veterinary Science, Animal Husbandry, Agriculture, Environmental Science, Fisheries, Food Science and Nutrition, Zoology, Plant Science and Botany, Marine Biology and Marine Science, Pharmaceutical Science, Genetic Engineering and Biotechnology, Microbiology, Public Health, Biochemistry, Cellular and Molecular Life Sciences and so on).

The following types of papers are included in Asian Journal of Medical and Biological Research: (1) Review articles, (2) Full length research articles, and (3) Short communications.

Online Submission

Submit your manuscript through eJManager (Online Manuscript Submission, Review and Tracking System). The submitted manuscript will be subjected to check for Similarity Index by applying iThenticate with the published papers in different journals and various internet sources.

Terms of Submission

Papers must be submitted on the understanding that they have not been published elsewhere and are not currently under consideration by another journal. It is assumed that all named authors  agree with the contents and form of the manuscript and are responsible for the validity and originality of data contained therein. It is the author’s responsibility to validate the contents of the manuscript, however, management of the AJMBR will not be responsible for the contents of manuscripts published.

Review Process

Articles submitted to Asian Journal of Medical and Biological Research are subject to strict peer-reviewing. Once a manuscript passes the initial checks, it will be assigned to at least two independent experts for peer-review. The journal operates a single blind peer-review (the reviewers know the authors’ identities, but the authors do not know the reviewers’ identities). The journal’s management will try to get the submitted manuscript reviewed as early as possible. Usually reviewers are requested to complete the review as early as possible; however, delay in the review process will not be on the part of AJMBR management. If all processes from complete submission to revision go smoothly, then 6-8 weeks are usually required to reach a conclusion (Acceptance/Rejection). For more details, please visit About AJMBR.

After Provisional Acceptance

Upon provisional acceptance of a paper for publication, the corresponding author will receive the email regarding payment of article processing charge. Charges must be paid within 10 days as per instructions given in the email. Acceptance will be final after the payment of publication charge.

Proof corrections: The corresponding author will receive an e-mail containing PDF (portable document format). The proof can be downloaded as a PDF. Proofs must be returned to the Editor within five days of receipt with corrections if any. If there is no correction then the corresponding author must reply accordingly. We ask that you only correct typesetting errors and grammatical errors if any. Please note that the author is responsible for all statements made in their work, including changes made.

Online publication: Online articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors’ final corrections have been incorporated. We do assign DOI to each newly published article. We will send the email to all authors once the article is published.

Reprints: Reprints will not be provided, if it is deemed necessary to have reprints, authors have to place order well in time on extra payment. Contact us if you have any questions.

General Guidelines for Manuscript Preparation

  • All materials must be written in standard english.
  • Manuscript must be double-spaced throughout.
  • Type written using 12 font size Times New Roman on A4 paper MS WORD format.
  • The page number and line number must be assigned throughout the manuscript continuously from the title page.
  • Divide your article (excluding abstract, keywords, acknowledgements, data availability, conflict of interest, authors’ contribution, and references) into clearly defined and numbered sections using Arabic numerals (1, 2, 3, etc.). Subsections should be numbered 1.1 (then 1.1.1, 1.1.2, …), 1.2, etc.
  • One of the manuscript author(s) should be corresponding author, who takes responsibility for the paper during submission and peer review.
  • Superscript numbers (1) should be used to link author with institution and an asterisk (*) to refer to the corresponding author.
  • The abbreviations and acronyms should be defined the first time they used in the manuscript.
  • Do not use abbreviations in the title until and unless they are unavoidable.
  • Use the standard mathematical notation for formulae/symbols.
  • Genus and species names should be in italics.
  • Internationally accepted (SI) signs and symbols should be used for units.
  • The Tables and Figures must not be submitted separately and should appear in the text after the reference section.
  • The cover letter, the manuscript (title page and main manuscript in a single file) and the signed copyright form should be included during manuscript submission.

Cover Letter: Download

Copyright Release Form: Download

Title Page: The following information should be included:

  • Type of article: Review/Research/Short Communication
  • Title (should be clear, descriptive and not too long)
  • Authors' full names and affiliations
  • Corresponding author: Ensure his / her full name, address, phone, fax and e-mail.

Main Manuscript Structure: The main manuscript should be in the following sequence:

  • Abstract
  • Keywords
  • Introduction
  • Materials and Methods
  • Results
  • Discussion
  • Or Results and Discussion
  • Conclusions
  • Acknowledgements
  • Data availability
  • Conflict of interest
  • Authors’ contribution
  • References
  • Tables
  • Figures

Abstract and Keywords

  • The abstract must be concise and informative providing the main aim of the work, methods, principal results, and conclusions.
  • An abstract of no more than 300 words (Review and Research Articles) or 100 words for Short Communication.
  • At the end of the abstract, keywords (3-6 words) related to the manuscript work must be provided for indexing, abstracting, and retrieval purposes.

Introduction

  • This section should contain a brief review of the problem with which the study deals, validate the approach taken, and formulate the goals.
  • This section should include recent references.

Materials and Methods

  • This section must include a statement regarding ethical approval of the study as a first subheading. If there is no need for approval for your study, then include the sentence accordingly.
  • This section must include a statement regarding ‘patient consent’ if applicable. For research articles, authors are required to state in the Materials and Methods section whether patients provided informed consent and whether the consent was written or verbal.
  • Authors are requested to refer to the reporting guidelines relevant to their study type e.g. CONSORT. The guidelines on reporting sex and gender information (SAGER) should also be considered. These guidelines can be found on the Equator Network.
  • This section must be clear and sufficient with experimental details to reproduce the works by other researchers.
  • Previously published procedures or methods should be cited without any detailed descriptions.
  • New procedures and techniques should be described in details.
  • Instruments and reagents information should be specified.
  • The source from which the sample has been obtained should be mentioned.

Results

  • This section should provide a concise and precise description of the experimental results, their interpretation, and the experimental conclusions that can be drawn.
  • Repetition of the same data in different forms should be avoided.

Discussion

  • Authors should discuss the results and how they can be interpreted from the perspective of previous studies (recent references) and the working hypotheses.
  • The findings and their implications should be discussed in the broadest context possible, and the limitations of the work should be highlighted.
  • This section may be combined with Results.

Conclusions

  • This section should clearly explain the work’s main conclusions, highlighting its importance and relevance, including any practical applications.
  • Future research directions may also be mentioned.

Acknowledgements

  • Under this section please specify contributors to the article other than the authors accredited.
  • This section must include information relating to supporting grants. You must have to include the details of the funding institute with address and grant number.
  • If there was no funding, the following wording should be used: “This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.”
  • Any suppliers of materials should be named and their location (town, state/county, country) included if appropriate.

Data availability

Authors are required to include a ‘Data availability’ section in their manuscript and this section should appear between the ‘Acknowledgements’ and the ‘Conflict of interest’. The intention of this section is to provide readers with information on where they can obtain the research data required to reproduce the work reported in the manuscript. This statement should describe how readers can access the data supporting the conclusions of the study and clearly outline the reasons why unavailable data cannot be released. Authors of papers that are not based on original data, such as Review articles, need not include a ‘Data availability’ section.

Conflict of interest

All authors must disclose any commercial or other association (e.g., pharmaceutical stock ownership, consultancy, advisory board membership, travel grants, relevant patents, or research funding) that might pose a conflict of interest regarding the submitted manuscript. The corresponding author will be responsible for obtaining the relevant information from all co-authors. Appropriate declarations or “None to declare” should appear at the end of the text under the subheading “Conflict of interest.” This applies to all papers.

Authors’ contribution

Individual contributions of authors should be specified in this section to give appropriate credit to each author. Place authors’ contribution before references.

References

  • All listed references must be cited in the text.
  • Arrange the references in alphabetical order by the first author’s surname.
  • The citation of references in text up to two author(s) should be surname followed by year of publication (Islam, 2010 or Islam and Hossain, 2013).
  • The citation of references in text more than two author(s) should be surname of first author followed by et al., and year of publication (Islam et al., 2013).
  • In case, an author cited has more than one publication during the same year should be identified by a lowercase letter (like a, b, c), both in the text and reference list to distinguish the works (Hossain et al., 2012a; 2012b).
  • Abbreviated Journal Name should be written.
  • Author(s) should check the references in the text and reference list carefully before submission to avoid delay in peer review and publication of the article.

Examples of Reference Styles:

Journal Articles:

  • Kabir SML, 2009. The role of probiotics in the poultry industry. Int. J. Mol. Sci., 10: 3531-3546.
  • Sugathan S and J Mandal, 2019. An in vitro experimental study of the effect of fosfomycin in combination with amikacin, ciprofloxacin or meropenem on biofilm formation by multidrug- resistant urinary isolates of Escherichia coli. J. Med. Microbiol., 68: 1699-1706.
  • Uddin MN, SB Neogi, SS Islam, J Ferdous, MSR Khan, S Yamasaki and SML Kabir, 2021. Occurrence and multidrug resistance of Campylobacter spp. at duck farms and associated environmental and anthropogenic risk factors in Bangladesh. BMC Infect. Dis., 21: 1139.

Conference Proceedings:

Kabir SML, M Asakura, S Shiramaru, A Pal, A Hinenoya and S Yamasaki, 2013. Identification and antimicrobial resistance profiles of Campylobacter strains of poultry origin in India with special emphasis on fluoroquinolone resistance. Proceedings of the 8th International Poultry Show and Seminar, 28 February-02 March 2013, Dhaka, Bangladesh. Edited by: World’s Poultry Science Association Bangladesh Branch, pp. 85-89.

Theses:

Kabir SML, 2011. Comparison of molecular methods for the species identification of clinical Campylobacter strains and their antimicrobial resistance. PhD thesis, Department of Veterinary Science, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Osaka, Japan. pp. 1-158.

Books:

Alam J and SML Kabir, 2017. Orf virus infection. LAP LAMBERT Academic Publishing, Germany.

Chapters in Books:

Kabir SML, MH Sikder, J Alam, SB Neogi and S Yamasaki, 2017. Colibacillosis and its impact on egg production. In: Egg Innovations and Strategies for Improvements. Edited by: Hester P, Elsevier, pp. 523-535.

Websites:

WHO, 2010. Avian influenza – situation in Vietnam-update 8. Available: http://www.who.int/csr/don/201 0_03_04a/en/index.html.

Unpublished Materials:

Leshner AI, 1996. Molecular mechanisms of cocaine addiction. N. Engl. J. Med., In press.

Tables

  • All tables should be numbered using Arabic numerals (Table 1, Table 2, Table 3, etc.).
  • Tables should always be cited in text in consecutive numerical order.
  • Each table should have a brief and self-explanatory title.
  • The vertical lines or rules should be avoided in the tables.
  • Duplication of the data in the tables and figures is not allowed.
  • All tables should be placed after the reference section.

Figures

  • All figures should be numbered using Arabic numerals (Figure 1, Figure 2, Figure 3, etc.).
  • Figures should always be cited in text in consecutive numerical order.
  • Figure parts should be denoted by lowercase letters (a, b, c, etc.).
  • Each figure should have a concise and self-explanatory legend.
  • The figures should have high resolutions (at least 300 dpi) with clarity.
  • This section should be presented after the end of tables.

Ethical Considerations

When reporting research involving human subjects or the use of materials of human origin, authors must obtain prior institutional authorization. Furthermore, authors must include a statement in an appropriate section declaring that all experiments were carried out in compliance with the relevant laws and guidelines, in accordance with the ethical standards of the Declaration of Helsinki.

Research using recombinant DNA implies that physical and biological containment conformed to the guidelines of a corresponding agency in the authors’ country.

Animal experiments must also be performed under institutional authorization and in compliance with relevant laws and guidelines in the authors’ country. Authors are encouraged to adhere to animal research reporting standards, for example the ARRIVE guidelines for reporting study design and statistical analysis; experimental procedures; experimental animals and housing and husbandry.

Publication Ethics Statement

Authors are advised to adhere strictly to the ethical standards as prescribed by the Committee on Publication Ethics (COPE).

The editors of this journal enforce a rigorous peer-review process together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, image manipulation, inappropriate authorship credit, and the like, do arise. The editors of AJMBR take such publishing ethics issues very seriously and are trained to proceed in such cases with a zero tolerance policy.

Authors wishing to publish their papers in AJMBR must abide to the following:

  • Any facts that might be perceived as a possible conflict of interest of the author(s) must be disclosed in the paper prior to submission.
  • Authors should accurately present their research findings and include an objective discussion of the significance of their findings.
  • Data and methods used in the research need to be presented in sufficient detail in the paper, so that other researchers can replicate the work.
  • Raw data should preferably be publicly deposited by the authors before submission of their manuscript. Authors need to at least have the raw data readily available for presentation to the referees and the editors of the journal, if requested. Authors need to ensure appropriate measures are taken so that raw data is retained in full for a reasonable time after publication.
  • Simultaneous submission of manuscripts to more than one journal is not tolerated.
  • Republishing content that is not novel is not tolerated (for example, an English translation of a paper that is already published in another language will not be accepted).
  • If errors and inaccuracies are found by the authors after publication of their paper, they need to be promptly communicated to the editors of this journal so that appropriate actions can be taken.
  • Your manuscript should not contain any information that has already been published. If you include already published figures or images, please obtain the necessary permission from the copyright holder to publish under the CC-BY license.
  • Plagiarism is not acceptable in AJMBR submissions. The policy of AJMBR is to publish only unplagiarized material. We check the submitted manuscript for similarity index by iThenticate. Highly similar articles are directly rejected. The plagiarism is counted excluding references.
  • Image files must not be manipulated or adjusted in any way that could lead to misinterpretation of the information provided by the original image.
  • Irregular manipulation includes: 1) introduction, enhancement, moving, or removing features from the original image; 2) grouping of images that should obviously be presented separately (e.g., from different parts of the same gel, or from different gels); or 3) modifying the contrast, brightness or color balance to obscure, eliminate or enhance some information.
  • If irregular image manipulation is identified and confirmed during the peer review process, we may reject the manuscript. If irregular image manipulation is identified and confirmed after publication, we may correct or retract the paper.

Allegations of Research Misconduct Policy

Our policy for managing allegations of research misconduct is based on the guidelines of the Committee on Publication Ethics (COPE).

Report of research misconduct may be related to a published article or a manuscript under peer-review process. The procedure for the application and management of complaints of author misconduct should proceed with sensitivity, tact, in confidence, and in the following manner:

  • The journal's editorial office receives a complaint via the contact form that an article submitted to or published in the journal is suspected of containing research misconduct.
  • The complainant needs to clearly indicate the specific manner and detail of misconduct; for example, in a case of plagiarism, the plagiarized paragraph should be clearly highlighted and the original and suspected articles should be referred to clearly.
  • The editorial office will conduct an investigation, during which time the editor of the journal and the corresponding author(s) of the suspected article will be in contact.
  • The corresponding author(s) will be asked to provide an explanation with factual statements and any available evidence.
  • If the author(s) of the suspected article accepts the misconduct complaint, the editorial office will take the following actions depending on the situation:
    • If the article has been published, an erratum or retraction may be necessary to remedy the situation. However, there may still be disagreement concerning the appropriate wording of the description.
    • If the misconduct is reported during the review process, the review process may continue, with the author(s) making the relevant changes.
  • In the case of nonresponse in the stipulated time or an unsatisfactory explanation, the article may be permanently retracted or rejected. Before making a decision, confirmation will be sought from the experts of the relevant institution or other authorities as required.
  • The complainant will be informed of the outcome once the issue is resolved.
  • The complaint case will thereupon be considered concluded.

Citation Policy

  • Authors should ensure that where material is taken from other sources (including their own published writing) the source is clearly cited and that where appropriate permission is obtained.
  • Authors should not engage in excessive self-citation of their own work.
  • Authors should not copy references from other publications if they have not read the cited work.
  • Authors should not preferentially cite their own or their friends’, peers’, or institution’s publications.
  • Authors should not cite advertisements or advertorial material.

In accordance with COPE guidelines, we expect that “original wording taken directly from publications by other researchers should appear in quotation marks with the appropriate citations.” This condition also applies to an author’s own work. COPE have produced a discussion document on citation manipulation with recommendations for best practice.

Authorship

AJMBR follows the International Committee of Medical Journal Editors (ICMJE) guidelines which state that, in order to qualify for authorship of a manuscript, the following criteria should be observed:

  • Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
  • Drafting the work or revising it critically for important intellectual content; AND
  • Final approval of the version to be published; AND
  • Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Those who contributed to the work but do not qualify for authorship should be listed in the acknowledgments. More detailed guidance on authorship is given by the International Council of Medical Journal Editors (ICMJE).

Any change to the author list should be approved by all authors including any who have been removed from the list. The corresponding author should act as a point of contact between the editor and the other authors and should keep co-authors informed and involve them in major decisions about the publication. We reserve the right to request confirmation that all authors meet the authorship conditions.

Editors and Journal Staff as Authors

Editors and journal staff shall not be involved in processing their academic work. Submissions authored by editors/journal staff will be assigned to at least two independent outside reviewers. Decisions will be made by other editorial board members who do not have conflict of interests with the authors.

Editorial Independence

Editorial independence is essential, and Ebu Press Ltd does not interfere with editorial decisions. All articles published by Ebu Press Ltd are peer-reviewed and assessed by our independent editorial boards, and Ebu Press Ltd staff are not involved in accepting manuscripts. When making an editorial decision, we expect the editorial board to make their decision based only upon:

  • The suitability of selected reviewers;
  • Adequacy of reviewer comments and author response;
  • Overall scientific quality of the paper.

Manuscript Withdrawal Policy

Withdrawal of manuscript after submission is strongly discouraged. If there is a strong reason for withdrawal, a request for withdrawal signed by all the authors clearly stating the reasons for withdrawal must be sent to the Editor-in-Chief. After acceptance by the Editor-in-Chief, the editorial office will provide the author with a manuscript withdrawal letter, and the manuscript will be withdrawn. It is not an acceptable practice to withdraw a manuscript after it has been sent for peer review.

Retraction Policy

As per COPE guidelines.

Article Types

Review articles: These provide concise and precise updates on the latest progress made in a given area of research. There is no specific format for review article. It is advised to refer the latest published review article of the journal for the format of manuscript preparation. Minimum 50% references must be from past five years.

Full length research articles: Original research manuscripts. The journal considers all original research manuscripts provided that the work reports scientifically sound experiments and provides a substantial amount of new information. Quality and impact of the study will be considered during peer review.

Short communications: Papers in brief form will be published as Short communications, with the understanding that this does not provide an accelerated means for publication.

Privacy Statement

Bangladesh Journals Online (BanglaJOL) is a member of the Ubiquity Partner Network coordinated by Ubiquity Press. According to the EU definitions, BanglaJOL is the data controller, and Ubiquity Press are the service providers and data processors. Ubiquity Press provide the technical platform and some publishing services to BanglaJOL and operate under the principle of data minimisation where only the minimal amount of personal data that is required to carry out a task is obtained.

More information on the type of data that is required can be found in Ubiquity Press’ privacy policy below.

Ubiquity Press Privacy Policy

We take seriously our duty to process your personal data in a fair and transparent way. We collect and manage user data according to the following Privacy Policy. This document is part of our Terms of Service, and by using the press portal, affiliated journals, book, conference and repository websites (the “Websites”), you agree to the terms of this Privacy Policy and the Terms of Service. Please read the Terms of Service in their entirety, and refer to those for definitions and contacts.

What type of personal data do we handle?

There are four main categories of personal data stored by our journal platform, our press platform, and our book management system; Website User data, Author data, Reviewer data and Editor data.

The minimum personal data that are stored are:

  • full name
  • email address
  • affiliation (department, and institution)
  • country of residence

Optionally, the user can provide:

  • salutation
  • gender
  • associated URL
  • phone number
  • fax number
  • reviewing interests
  • mailing address
  • ORCiD
  • a short biography
  • interests
  • Twitter profile
  • LinkedIn profile
  • ImpactStory profile
  • profile picture

The data subjects have complete control of this data through their profile, and can request for it to be removed by contacting info@ubiquitypress.com

What do we do to keep that data secure?

We regularly backup our databases, and we use reliable cloud service providers (Amazon, Google Cloud, Linode) to ensure they are kept securely. Backups are regularly rotated and the old data is permanently deleted. We have a clear internal data handling policy, restricting access to the data and backups to key employees only. In case of a data breach, we will report the breach to the affected users, and to the press/journal contacts within 72 hours.

How do we use the data?

Personal information is only used to deliver the services provided by the publisher. Personal data is not shared externally except for author names, affiliations, emails, and links to ORCiD and social media accounts (if provided) in published articles and books which are displayed as part of the article/book and shared externally to indexes and databases. If a journal operates under open peer review then the reviewer details are published alongside the reviewer details.

How we collect and use your data:

1. When using the website

1.1 what data we collect

  • When you browse our website, we collect anonymised data about your use of the website; for example, we collect information about which pages you view, which files you download, what browser you are using, and when you were using the site.
  • When you comment on an article or book using Disqus, we are not collecting, controlling or processing the data. More details on the DISQUS privacy policy can be found on their website.
  • When you annotate an article or book, this is done via a 3rd party plugin to the website called Hypothes.is. In using this plugin we are not collecting, controlling or processing the data. More details on the Hypothes.is privacy policy can be found on their website.

1.2 why we collect the data

  • We use anonymised website usage data to monitor traffic, help fix bugs, and see overall patterns that inform future redesigns of the website, and provide reports on how frequently the publications on our site have been accessed from within their IP ranges.

1.3 what we do (and don’t do) with the data

  • We do not collect personal information that can be used to identify you when you browse the website.
  • We currently use Google Analytics for publication reports, and to improve the website and services through traffic analysis, but no personal identifying data is shared with Google (for example your computer’s IP is anonymised before transmission).

1.4 what to do if you want to get a copy of your data, or want your data to be removed

  • Please contact info@ubiquitypress.com to request a copy of your data, or for your data to be removed/anonymised.

2. When registering as an author, and submitting an article or book

2.1 what data we collect

  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • As part of submitting an article for publication, you will need to provide personally identifying information which will be used for the peer review process, and will be published. This can include ‘Affiliation’, ‘Competing interests’, ‘Acknowledgements’.

2.2 why we collect the data

  • Registering an account allows you to log in, manage your profile, and participate as an author/reviewer/editor. We use cookies and session information to streamline your use of the website (for example in order for you to remain logged-in when you return to a journal). You can block or delete cookies and still be able to use the websites, although if you do you will then need to enter your username and password to login. In order to take advantage of certain features of the websites, you may also choose to provide us with other personal information, such as your ORCiD, but your decision to utilize these features and provide such data will always be voluntary.
  • Personal data submitted with the article or book is collected to allow follow good publication ethics during the review process, and will form part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.3 what we do (and don’t do) with the data

  • We do not share your personal information with third parties, other than as part of providing the publishing service.
  • As a registered author in the system you may be contacted by the journal editor to submit another article.
  • Any books published on the platform are freely available to download from the publisher website in PDF, EPUB and MOBI formats on the publisher’s site.
  • Any personal data accompanying an article or a book (that will have been added by the submitting author) is published alongside it. The published data includes the names, affiliations and email addresses of all authors.
  • Any articles published on the platform are freely available to download from the publisher website in various formats (e.g. PDF, XML).
  • Ubiquity Press books and articles are typeset by SiliconChips and Diacritech.This process involves them receiving the book and book associated metadata and contacting the authors to finalise the layout. Ubiquity Press work with these suppliers to ensure that personal data is only used for the purposes of typesetting and proofing.
  • For physical purchases of books on the platform Ubiquity Press use print on demand services via Lightning Source who are responsible for printing and distribution via retailers. (For example; Amazon, Book Repository, Waterstones). Lightning Source’s privacy policy and details on data handling can be found on their website.

2.4 why we store the data

  • We store the account data so that you may choose to become a reviewer and be able to perform those tasks, or to become an author and submit an article and then track progress of that article.
  • Published personal data that accompanies an article or a book forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.5 what to do if you want to get a copy of your data, or want your data to be removed

  • You are able to view, change and remove your data associated with your profile. Should you choose to completely delete your account, please contact us at support@ubiquitypress.com and we will follow up with your request as soon as possible.
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

3. When registering as a reviewer

3.1 what data we collect

  • To become a reviewer you must first register as a user on the website, and set your preference that you would like to be considered as a reviewer. No new personal data is collected when a registered user elects to become a reviewer.
  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • Reviewers can also be registered by editors who invite them to review a specific article. This requires the editor to provide the reviewer’s First Name, Last Name, and Email address. Normally this will be done as part of the process of inviting you to review the article or book.
  • On submitting a review, the reviewer includes a competing interest statement, they may answer questions about the quality of the article, and they will submit their recommendation.

3.2 why we collect the data

  • The data entered is used to invite the reviewer to peer review the article or book, and to contact the reviewer during and the review process.
  • If you submit a review then the details of your review, including your recommendation, your responses to any review form, your free-form responses, your competing interests statement, and any cover letter are recorded.

3.3 what we do (and don’t do) with the data

  • This data is not shared publicly and is only accessible by the Editor and system administrators of that journal or press.
  • The data will only be used in connection with that journal or press.
  • Data that is retained post final decision is kept to conform to publication ethics and best practice, to provide evidence of peer review, and to resolve any disputes relating to the peer review of the article or book.
  • For journals or presses that publish the peer reviews, you will be asked to give consent to your review being published, and a subset of the data you have submitted will become part of the published record.

3.4 what to do if you want to get a copy of your data, or want your data to be removed

  • If you would no longer like to be registered as a reviewer you can edit your profile and tick the box ‘stop being a reviewer’. This will remove you from the reviewer database, however any existing reviews you may have carried out will remain.
  • If you have been contacted by an editor to peer review an article this means that you have been registered in the system. If you would not like to be contacted for peer review you can reply to the email requesting that your data be deleted.

4. When being registered as a co-author

4.1 what data we collect

  • Co-author data is entered by the submitting author. The submitting author will already have a user account. According to standard publishing practice, the submitting author is responsible for obtaining the consent of their co-authors to be included (including having their personal data included) in the article/book being submitted to the journal/press.
  • The requested personal data for co-authors are at the bare minimum; first name, last name, institution, country, email address. This can also include; ORCID ID, Title, Middle Name, Biographical Statement, Department, Twitter Handle, Linkedin Profile Name or ImpactStory ID.

4.2 why we collect the data

  • Assuming that it is accepted for publication, this data forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.
  • Author names, affiliations and emails are required for publication and will become part of the permanent cited record.

4.3 what we do (and don’t do) with the data

  • The co-author’s personal data is stored in the author database. This personal data is only used in relation to the publication of the associated article.
  • Any co-author data collected is added to the author database and is only used in association with the article the user is co-author on.

4.5 what to do if you want to get a copy of your data, or want your data to be removed

  • To receive a copy of your data, please contact info@ubiquitypress.com
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

5. When signing-up to receive newsletters

5.1 what data we collect

  • We require you to include your name and email address

5.2 why we collect and store the data, and for how long

  • This data would be collected to keep you updated with any news about the platform or specific journal

5.3 what we do (and don’t do) with the data

  • We use mailchimp to provide our mailing list services. Their privacy policy can be found here

5.4 what to do if you want to get a copy of your data or want your data to be removed

  • All emails sent via our newsletter client will include a link that will allow you to unsubscribe from the mailing list

Notification about change of ownership or of control of data

We may choose to buy or sell assets. In the case that control of data changes to or from Ubiquity Press and a third party, or in the case of change of ownership of Ubiquity Press or of part of the business where the control of personal data is transferred, we will do our best to inform all affected users and present the options.

(Updated: 18 May 2018)